Annual Accounts Payable
$4.45 M
+$481.00 K+12.13%
December 31, 2023
Summary
- As of February 8, 2025, LVTX annual accounts payable is $4.45 million, with the most recent change of +$481.00 thousand (+12.13%) on December 31, 2023.
- During the last 3 years, LVTX annual accounts payable has risen by +$3.51 million (+376.02%).
- LVTX annual accounts payable is now at all-time high.
Performance
LVTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.81 M
-$1.35 M-32.35%
September 30, 2024
Summary
- As of February 8, 2025, LVTX quarterly accounts payable is $2.81 million, with the most recent change of -$1.35 million (-32.35%) on September 30, 2024.
- Over the past year, LVTX quarterly accounts payable has dropped by -$6.57 million (-70.00%).
- LVTX quarterly accounts payable is now -70.00% below its all-time high of $9.38 million, reached on September 30, 2023.
Performance
LVTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
LVTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.1% | -70.0% |
| 3 y3 years | +376.0% | -70.0% |
| 5 y5 years | +953.5% | -70.0% |
LVTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +74.2% | -70.0% | +10.3% |
| 5 y | 5-year | at high | +953.5% | -70.0% | +201.4% |
| alltime | all time | at high | +953.5% | -70.0% | +201.4% |
LAVA Therapeutics NV Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.81 M(-32.3%) |
| Jun 2024 | - | $4.16 M(+21.1%) |
| Mar 2024 | - | $3.44 M(-22.7%) |
| Dec 2023 | $4.45 M(+12.1%) | $4.45 M(-52.6%) |
| Sep 2023 | - | $9.38 M(+85.2%) |
| Jun 2023 | - | $5.07 M(+62.6%) |
| Mar 2023 | - | $3.12 M(-21.4%) |
| Dec 2022 | $3.96 M | $3.96 M(-49.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $7.80 M(+166.2%) |
| Jun 2022 | - | $2.93 M(+10.3%) |
| Mar 2022 | - | $2.66 M(+4.0%) |
| Dec 2021 | $2.55 M(+173.3%) | $2.55 M(+33.7%) |
| Sep 2021 | - | $1.91 M(-11.8%) |
| Jun 2021 | - | $2.17 M(+26.2%) |
| Mar 2021 | - | $1.72 M(+83.7%) |
| Dec 2020 | $934.00 K(+121.3%) | $934.00 K |
| Dec 2019 | $422.00 K | - |
FAQ
- What is LAVA Therapeutics NV annual accounts payable?
- What is the all time high annual accounts payable for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual accounts payable year-on-year change?
- What is LAVA Therapeutics NV quarterly accounts payable?
- What is the all time high quarterly accounts payable for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly accounts payable year-on-year change?
What is LAVA Therapeutics NV annual accounts payable?
The current annual accounts payable of LVTX is $4.45 M
What is the all time high annual accounts payable for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual accounts payable is $4.45 M
What is LAVA Therapeutics NV annual accounts payable year-on-year change?
Over the past year, LVTX annual accounts payable has changed by +$481.00 K (+12.13%)
What is LAVA Therapeutics NV quarterly accounts payable?
The current quarterly accounts payable of LVTX is $2.81 M
What is the all time high quarterly accounts payable for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly accounts payable is $9.38 M
What is LAVA Therapeutics NV quarterly accounts payable year-on-year change?
Over the past year, LVTX quarterly accounts payable has changed by -$6.57 M (-70.00%)